Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis

Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) was approved in Canada in May 2017, but its effectiveness in a real‐world setting has not been described. We sought...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hepatol Commun
Main Authors: Roberts, Surain B., Ismail, Marwa, Kanagalingam, Gowthami, Mason, Andrew L., Swain, Mark G., Vincent, Catherine, Yoshida, Eric M., Tsien, Cynthia, Flemming, Jennifer A., Janssen, Harry L.A., Hirschfield, Gideon M., Hansen, Bettina E., Gulamhusein, Aliya F.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471421/
https://ncbi.nlm.nih.gov/pubmed/32923836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1518
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki